References
- Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):359–86.
- Blumer SL, Anupindi SA, Adamson PC, Lin H, Price AP, Markowitz RI, et al. Sporadic adenocarcinoma of the colon in children: case series and review of the literature. J Pediatr Hematol Oncol. 2012;34(4):137–41.
- Poles GC, Clark DE, Mayo SW, Beierle EA, Goldfarb M, Gow KW, Goldin A, Doski JJ, Nuchtern JG, Vasudevan SA, et al. Colorectal carcinoma in pediatric patients: a comparison with adult tumors, treatment and outcomes from the National Cancer Database. J Pediatr Surg. 2016;51(7):1061–6. doi:https://doi.org/10.1016/j.jpedsurg.2015.11.005.
- Koh KJ, Lin LH, Huang SH, Wong JU. CARE-pediatric colon adenocarcinoma: a case report and literature review comparing differences in clinical features between children and adult patients. Medicine (Baltimore.) 2015;94(6):e503. doi:https://doi.org/10.1097/MD.0000000000000503.
- Tiwari C, Zadpe A, Rathi P, Shah H. An unusual presentation of rectal carcinoma in a child. Pediatr Gastroenterol Hepatol Nutr. 2018;21(1):72–5. doi:https://doi.org/10.5223/pghn.2018.21.1.72.
- Karoui M, Tresallet C, Brouquet A, Radvanyi H, Penna C. Colorectal carcinogenesis: underlying epigenetic and genetic alterations and molecular classification of colorectal cancers. J Chir. 2007;144(2):97–104. doi:https://doi.org/10.1016/S0021-7697(07)89480-4.
- Hamelin R, Chalastanis A, Colas C, El Bchiri J, Mercier D, Schreurs A-S, Simon V, Svrcek M, Zaanan A, Borie C, et al. Clinical and molecular consequences of microsatellite instability in human cancers. Bull Cancer. 2008;95(1):121–32. doi:https://doi.org/10.1684/bdc.2008.0571.
- Overbeek LI, Ligtenberg MJ, Willems RW, Hermens RP, Blokx WA, Dubois SV, et al. Interpretation of immunohistochemistry for mismatch repair proteins is only reliable in a specialized setting. Am J Surg Pathol. 2008;32(8):1246–51.
- Rossi S, Kopetz S, Davuluri R, Hamilton SR, Calin GA. MicroRNAs, ultraconserved genes and colorectal cancers. Int J Biochem Cell Biol. 2010;42(8):1291–7. doi:https://doi.org/10.1016/j.biocel.2009.05.018.
- Curtin K, Slattery ML, Samowitz WS. CpG island methylation in colorectal cancer: past, present and future. Pathol Res Int. 2011;2011:902674. doi:https://doi.org/10.4061/2011/902674.
- Samowitz WS, Sweeney C, Herrick J, Albertsen H, Levin TR, Murtaugh MA, Wolff RK, Slattery ML. Poor survival associated with the BRAF V600E mutation in microsatellite-stable colon cancers. Cancer Res. 2005;65(14):6063–9. doi:https://doi.org/10.1158/0008-5472.CAN-05-0404.
- Ducreux M, Chamseddine A, Laurent-Puig P, Smolenschi C, Hollebecque A, Dartigues P, Samallin E, Boige V, Malka D, Gelli M, et al. Molecular targeted therapy of BRAF-mutant colorectal cancer. Ther Adv Med Oncol. 2019;11:1758835919856494–15. doi:https://doi.org/10.1177/1758835919856494.
- Yoshida N, Kinugasa T, Ohshima K, Yuge K, Ohchi T, Fujino S, Shiraiwa S, Katagiri M, Akagi Y. Analysis of Wnt and β-catenin expression in advanced colorectal cancer. Anticancer Res. 2015;35(8):4403–10.
- Kwon JH, Jeong BK, Yoon YS, Yu CS, Kim J. Utility of BRAF VE1 immunohistochemistry as a screening tool for colorectal cancer harboring BRAF V600E mutation. J Pathol Transl Med. 2018;52(3):157–63. doi:https://doi.org/10.4132/jptm.2018.03.28.
- Abdel-Rahman O. Targeting BRAF aberrations in advanced colorectal carcinoma: from bench to bedside. Fut Oncol. 2016;12(1):25–30. doi:https://doi.org/10.2217/fon.15.226.
- Durno C, Aronson M, Bapat B, Cohen Z, Gallinger S. Family history and molecular features of children, adolescents, and young adults with colorectal carcinoma. Gut. 2005;54(8):1146–50.